Literature DB >> 6265428

The combination of pivmecillinam and pivampicillin in the treatment of acute enteric fever.

D Tanphaichitra, A Bussayanond, O Christensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6265428     DOI： 10.1093/jac/8.1.23

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  11 in total

Review 1.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

Review 2.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

3.  Multiple-dose pharmacokinetics of ceftazidime in cancer patients.

Authors:  I Garcia; V Fainstein; R G Smith; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

4.  Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections.

Authors:  D Tanphaichitra; S Sahaphong; S Srimuang
Journal:  Infection       Date:  1986       Impact factor: 3.553

5.  Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections.

Authors:  M Joshi; W C Anthony; J H Tenney; G L Drusano; E S Caplan; H C Standiford; A Henson; J W Warren
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

6.  In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents.

Authors:  A Tsuji; A Maniatis; M A Bertram; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

7.  The combination of pivmecillinam and pivampicillin compared to co-trimoxazole in the treatment of enteric fever.

Authors:  D Tanphaichitra; A Bussayanond; O Christensen
Journal:  Infection       Date:  1982       Impact factor: 3.553

8.  Randomized comparison of ceftazidime versus clindamycin-tobramycin in the treatment of obstetrical and gynecological infections.

Authors:  J D Blanco; R S Gibbs; P Duff; Y S Castaneda; P J St Clair
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  The combination of pivmecillinam and pivampicillin in the treatment of enteric fever.

Authors:  D Tanphaichitra; S Srimuang; P Chiaprasittigul; P Menday; O E Christensen
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

10.  Ceftazidime as single-agent therapy for gram-negative aerobic bacillary osteomyelitis.

Authors:  M C Bach; D M Cocchetto
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.